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Institute of Standards and Technology, Gaithersburg, MarylandABSTRACT The last decade established that the dynamic properties of the phosphoproteome are central to function and its
modulation. The temporal dimension of phosphorylation effects remains nonetheless poorly understood, particularly for intrin-
sically disordered proteins. Osteopontin, selected for this study due to its key role in biomineralization, is expressed in many
species and tissues to play a range of distinct roles. A notable property of highly phosphorylated isoforms of osteopontin is their
ability to sequester nanoclusters of calcium phosphate to form a core-shell structure, in a fluid that is supersaturated but stable.
In Biology, this process enables soft and hard tissues to coexist in the same organism with relative ease. Here, we extend our
understanding of the effect of phosphorylation on a disordered protein, the recombinant human-like osteopontin rOPN. The so-
lution structures of the phosphorylated and unphosphorylated rOPN were investigated by small-angle x-ray scattering and no
significant changes were detected on the radius of gyration or maximum interatomic distance. The picosecond-to-nanosecond
dynamics of the hydrated powders of the two rOPN forms were further compared by elastic and quasi-elastic incoherent neutron
scattering. Phosphorylation was found to block some nanosecond side-chain motions while increasing the flexibility of other side
chains on the faster timescale. Phosphorylation can thus selectively change the dynamic behavior of even a highly disordered
protein such as osteopontin. Through such an effect on rOPN, phosphorylation can direct allosteric mechanisms, interactions
with substrates, cofactors and, in this case, amorphous or crystalline biominerals.INTRODUCTIONOsteopontin and biomineralization
Osteopontin (OPN) is one of the main regulators of miner-
alization in hard and soft tissues, as well as biofluids
(1–5). In bovine milk, the most abundant phosphoform is
OPN1-149, formed by cleavage at or around residue 149
(6). In human urine, a much less phosphorylated peptide
known as ‘‘uropontin’’ appears to be the most common
form (7,8). In mineralized tissues multiple short OPN frag-
ments are found, as a result of the action of the protease
PHEX (9). Phosphorylated OPN has been shown to mediate
the intrafibrillar mineralization of collagen and activation of
osteoclasts (10,11), as well as nucleation, growth, and pre-Submitted November 9, 2016, and accepted for publication March 6, 2017.
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creativecommons.org/licenses/by-nc-nd/4.0/).cipitation of calcium phosphate (12–14). The function of
OPN is highly reliant on tissue-specific posttranslational
processing (see for example (15,16)), including phosphory-
lation by the Golgi FAM20C (17,18) and other kinases,
N- and O-glycosylation (4), and proteolysis (19). A variety
of structural methods, including nuclear magnetic resonance
(NMR) spectroscopy, synchrotron radiation circular dichro-
ism, and small-angle x-ray scattering (SAXS), have been de-
ployed to study various osteopontin peptides (20–24).
A critical point of regulation in physiological biomineral-
ization is the initial formation of an amorphous hydrated
phase of calcium phosphate, susceptible to control by inter-
actions with phosphoproteins (25–27). OPN contains multi-
ple sites of phosphorylation, which can cluster in the
so-called phosphate centers (PCs): a sequence of 10 or fewer
consecutive residues containing at least three sites of phos-
phorylation, no cysteines and fewer than three hydrophobic
Effect of Phosphorylation on Osteopontinresidues, as per the definition used in Holt et al. (22). Bovine
OPN1-149 can sequester amorphous calcium phosphate
through interactions involving its three PCs, forming nano-
structures in which the core is surrounded by a shell of
the phosphopeptides (28). Similar structures can be formed
by casein phosphopeptides containing a single PC (see for
example (29)).Phosphorylation of intrinsically disordered
proteins
The majority of mammalian proteins are phosphorylated
(30) and phosphorylation sites are frequently found in disor-
dered regions of protein structure (31). Phosphorylation
serves dynamic cellular processes well (32–34), due to its
reversibility and fast kinetics. Intrinsically disordered pro-
teins (IDPs) can gain regular secondary structure or fold
into a more compact state upon phosphorylation, with impli-
cations for their properties and function (35). Osteopontin
generally shows random coil-like behavior, but quail OPN
contains distinct local secondary structure elements with
reduced conformational flexibility (36). Hyperphosphoryla-
tion of Tau, a known substrate of the protein kinase CK2
(37), has been associated with amyloid fibril formation in
Alzheimer’s disease (38) and even subtle changes in confor-
mational dynamics can dictate amyloidogenicity (39). In
some Tau fragments, phosphorylation promotes the forma-
tion of, or stabilizes, poly-L-proline type II a-helical struc-
tures, while elsewhere in the sequence phosphorylation has
no apparent structural effect (40). Furthermore, phosphory-
lation can also promote disorder (41): studies of kinase sub-
strates (42) highlighted that phosphorylation by CK2 can
stabilize helix unfolding.
Phosphorylation and disordered conformations are
common among proteins controlling biomineralization
(22,43,44). The modulating role of phosphorylation on the
biological functions of OPN and other proteins is widely
recognized, allowing for OPN to interact with prenucleation
clusters (45), step-specific interactions with crystal sur-
faces, and by altering mineral interfacial energies (46,47)
where the extent of phosphorylation has also been shown
to have an impact (48). The mapping of specific effects of
phosphorylation are nevertheless poorly understood, partly
due to difficulties in determining phosphorylation stoichi-
ometry (see, for example, (49)), but mostly due to the chal-
lenges of producing phosphoproteins in high yields with
quantitative and complete phosphorylation at specific sites.
With significant progress in both fields—for a discussion,
see, for example, Oza et al. (50)—the time is ripe for studies
of phosphorylation effects at different time and length
scales (51–53). Here we compare the SAXS solution struc-
tures of phosphorylated and unphosphorylated rOPN. Infor-
mation on the internal dynamics of rOPN hydrated powders
was collected on two neutron spectrometers to cover a broad
frequency range. In the hydrated powder state, the center-of-mass diffusion of rOPN is suppressed, thus providing
unambiguous access to the internal molecular fluctua-
tions probed by the hydrogen atoms, uniformly distributed
throughout the rOPN sequence. Data were obtained from
elastic (EINS) and quasi-elastic (QENS) incoherent neutron
scattering (54). EINS provides mean square displacements,
a geometrical signature of the dynamical confinement,
while QENS allows vibrational and diffusive dynamics to
be distinguished.MATERIALS AND METHODS
Protein expression, purification, and preliminary
characterization
Phosphorylated and unphosphorylated rOPN peptides were produced.
A comparison to the bovine OPN1–149 peptide guided the design of a
human-like rOPN (Fig. S1). Albeit with limited success in terms of control-
ling the phosphorylation sites, the rOPN sequence was chosen with the aim
of decreasing the number of PCs, to produce a homogeneous functional
sample. Disorder predictions and a charge-hydropathy analysis of rOPN
was carried out using the PONDRVLX2 algorithm (PONDR.com), which
allowed comparisons to be made with sets of folded and unfolded proteins
(see Supporting Material for more details).
Unphosphorylated rOPN was produced by overexpression of a construct
in Escherichia coli as described in Clegg and Holt (55). Phosphorylated
rOPN was coexpressed with a constitutive serine/threonine kinase—mostly
serine (42)—with increased expression and activity in numerous cancers
(56). A second plasmid contained an IPTG-inducible a-subunit of casein
kinase on a pACYC Duet vector. The latter includes a chloramphenicol
resistance gene, allowing for dual selection for OPN and kinase clones,
in the presence of their respective antibiotics. For both rOPN forms, a final
purification step was carried out by size exclusion chromatography, using a
24 mL column packed with Superdex S75 resin (GE Healthcare, Little
Chalfont, UK), preequilibrated with two column-volumes of buffer
(50 mM phosphate pH 7.5, 300 mM NaCl and 0.02% NaN3: where M de-
notes molar concentrations in mol/L). Electron spray ionization mass spec-
trometry measurements were carried out on the two rOPN forms, at the
Grenoble platform service of the Partnership for Structural Biology (Greno-
ble, France).
The ability of the phosphorylated rOPN peptide to stabilize calcium
phosphate nanoclusters, like the native OPN, was tested using dynamic
light scattering (DLS): samples of 10 mg/mL were prepared in phosphate
buffer, as per the method of Holt et al. (22), and allowed to stabilize.
DLS of the corresponding solution was measured on a Zetasizer unit (Mal-
vern Instruments, Malvern, UK), with an incident wavelength of 633 nm. At
least 10 consecutive measurements of the correlation time of the scattered
light intensity were performed and averaged for each sample. The data were
fitted using the Malvern analysis software package (Malvern Instruments).Limited proteolysis by proteinase K
Limited proteolysis was carried out on the rOPN peptides with proteinase
K (Sigma-Aldrich, St. Louis, MO), according to the method of Denning
et al. (57). Equine skeletal muscle myoglobin (Sigma-Aldrich) was also
lysed for comparison with a globular protein of similar molecular weight
(17 kDa) to the unphosphorylated rOPN. A 5 mg sample of each protein
was incubated with 100 ng of proteinase K at 37C. Aliquots were removed
after 1, 2, 5, 10, 15, 30, and 60 min and the proteolysis was stopped by
boiling the aliquots dispersed in sodium dodecylsulfate (SDS) loading
buffer. They were then loaded onto an SDS-polyacrylamide gel electropho-
resis (PAGE) (12% polyacrylamide) gel and stained with Coomassie Blue.Biophysical Journal 112, 1586–1596, April 25, 2017 1587
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NMR spectra of phosphorylated and unphosphorylated rOPN were
measured on a Varian 600 MHz spectrometer (Agilent Technologies, Santa
Clara, CA) at the Institut de Biologie Structurale (Grenoble, France). The
1D 1H HET-SOFAST technique allows for a semiquantitative characteriza-
tion of the polypeptide disorder in solution, by comparison to empirical
thresholds defined as benchmarks for protein compactness (58) through a
measurement of the 1H-1H spin diffusion or NOE effect (lNOE). All mea-
surements were performed at room temperature, with 150 mM protein in
a solution containing 200 mM NaCl and 50 mM phosphate buffer, pH 7.SAXS
SAXSmeasurements were performed on the rOPN peptides, using an online
HPLC system (Viscotek GPCmax; Malvern Instruments) at the BM29 Bio-
SAXS beamline of the European Synchrotron Radiation Facility (Grenoble,
France). A 2.4 mL Superdex 200 Increase 5/150 GL column (GE Health-
care) was used and calibrated with protein standards (Bio-Rad, Hercules,
CA). Before each run, the column was equilibrated with two column-vol-
umes of buffer (50 mM phosphate pH 7.5, 300 mM NaCl, 0.02% NaN3).
A sample of 100 mL was loaded onto the column and eluted at a flow rate
of 0.1 mL/min. The elution was monitored by absorption at 280 nm.
X-ray scattering data were collected on the eluate as a function of the
scattered wave vector (q ¼ 4psinq/l), where 2q is the scattering angle
and the q range covered was 0.08–4 nm1. Data were collected at a wave-
length l of 0.99 A˚ and at 1 frame every 2 s. Radially integrated, calibrated
and normalized one-dimensional scattering profiles were obtained with the
EDNA software pipeline (59). All repeat frames were compared to monitor
radiation damage and exclude outliers from the averaging. Buffer frames
were also averaged for background subtraction. Radii of gyration (Rg)
were extracted from the x-ray data for the rOPN peptides. The Guinier
equation was used to fit the data close to the zero scattering angle:
ln IðqÞ ¼ ln Ið0Þ--ð1=3ÞR2gq2; (1)
where I(0) is the forward scattering intensity. A Kratky plot of q2I(q)/I(0) as
a function of q was also used as a qualitative estimation of protein compact-ness (60). The real-space pair distribution function P(r) was calculated by
indirect Fourier transform using GNOM from the ATSAS package (61).
The ensemble optimization method was used to produce an ensemble of
structures, taking into account protein flexibility by allowing the coexis-
tence of several different conformational isomers in the scattering solution
(62). A pool of 10,000 random models was generated, based on the primary
structure of the rOPN peptides. A genetic algorithm was then employed to
select the 50 models that best fit the scattering curve.Incoherent neutron scattering
Neutron spectroscopy provides the possibility to explore the hierarchy
of geometrically confined, superimposed motions as a function of (recip-
rocal) observation length and time, and a direct verification of molecular
dynamics simulations that provide space-time trajectories. Data were
collected on two spectrometers: IRIS (63), at the ISIS pulsed Neutron
and Muon source (Chilton, UK) and IN16B (64), at the Institut Laue Lan-
gevin (ILL, Grenoble, France). IRIS and IN16B cover similar momentum
transfer q ranges of 0.3–1.85 and 0.1–1.8 A˚1, respectively, but differ in en-
ergy resolution: 17 meV (150 ps, IRIS) and 0.8 meV (4 ns, IN16B). Monitor
normalization was performed for all data, and the detectors were calibrated
by using the sample signal from the lowest-temperature data.
The rOPN samples were in the form of D2O-hydrated powders, obtained
through three cycles of drying under vacuum and resuspension in D2O.
Each sample contained 100 mg of protein powder, with 0.44 g of D2O
per gram of protein (determined by interrupting the drying and weighting
of the sealed sample to monitor when the desired weight was obtained).1588 Biophysical Journal 112, 1586–1596, April 25, 2017Fixed window elastic scans were measured while the temperature was
continuously increased from 10 to 310 K at a rate of 1 K/min. The sample
was sealed in a flat aluminum cell with an internal spacing of 0.3 mm, at an
angle of 135 with respect to the incident beam. The so-called apparent
mean square displacements (MSD; hu2i) were obtained from analysis of
the integrated intensity over the frequency window corresponding to
the instrumental resolution around the elastic peak. The incoherent scat-
tering from the rOPN nonlabile hydrogen atoms largely dominates the
EINS signal: average MSD of the hydrogen atoms were extracted from
the q-dependence of the scattered intensity (energy transfer u), using a
q4 model correction (65) to the Gaussian approximation:
ln Iðq;u ¼ 0Þ ¼ hu
2iq2
3
þ a q4 þ c: (2)
The distinctly nonvanishing a2 q4 term illustrates the deviation of the
observed motion from the Gaussian approximation, significantly improvingthe fit to the data and allowing for a maximum of the measured q2 informa-
tion to be used in the fits: 0.19–3.4 A˚2 for IRIS data, and 0.19–1.6 A˚2 for
IN16B data.
Quasi-elastic spectra at selected temperatures were also recorded at
both the IRIS and IN16B spectrometers. The choppers and the Doppler
drive were set to allow for an energy transfer range of 530 meV on
IN16B, whereas the chopper settings on IRIS allowed for energy transfers
of5500 meV. For IRIS data, the empty cell signal introduced errors (most
likely due to nonmatching geometrical orientations) if subtracted. As the
empty cell Debye-Waller factor of the aluminum in the q-dependence is a
very small contribution, this data was not used. It is, however, represented
by the elastic signal—a free parameter in the QENS fits. It may slightly
affect the result for the fraction of immobile atoms (Fig. S11), but again
its contribution can be assumed to be nearly constant in q.RESULTS AND DISCUSSION
Recombinant protein expression and levels of
phosphorylation
Phosphorylated and unphosphorylated rOPN were purified
to homogeneity, as determined by SDS-PAGE and Western
blots. The deconvoluted electrospray ionization time-of-
flight mass spectrum of the unphosphorylated rOPN pro-
duced one clear peak at 18.115 kDa, consistent with the
theoretical molecular weight. This excludes the possibility
of prokaryotic phosphorylation—for a review, see Macek
et al. (66)—and validates the use of E. coli as a heterologous
expression host for studies of CK2 phosphorylation of
rOPN. The equivalent spectrum for the phosphorylated
rOPN sample (Fig. S8) showed a distribution of peaks,
differing by multiples of the mass of a phosphate group.
With the information currently available on CK2 recogni-
tion frequencies or patterns, often biased by kinase priming
of phosphorylation by another kinase, inferring a trend in
the results would be speculative. The rOPN samples were
designed assuming a distinct preference by a consensus
sequence (see also the Supporting Material) that, by itself,
is not consistent with the higher incidence of 4–9 phosphor-
ylation sites. For the purposes of comparing phosphoryla-
tion effects on the structure and dynamics of the two
rOPN isoforms, however, this is not a central issue.
The size of calcium phosphate nanoclusters formed
by phosphorylated peptides is not only dependent upon
Effect of Phosphorylation on Osteopontinphosphorylation but also the sequence and length of the chain
surrounding the phosphorylated region. We observed that
phosphorylated rOPN forms calcium phosphate nanoclusters
(CPN) in a solution that is supersaturated with respect to the
bone and tooth mineral hydroxyapatite. Notwithstanding
this, the solution is stable because it is undersaturated with
respect to the obligate precursor amorphous phase (22,26).
The solutions of the nanocluster complexes remained clear
after storage for prolonged periods and the absence of aggre-
gation was confirmed by the DLS results (Fig. S9). The size
of the nanoclusters agrees with the 22-nm radius of gyration
of CPN previously determined for bovine OPN1-149 (22),
consistent with themode of calcium phosphate binding being
similar for rOPN.Flexibility of rOPN structure in solution
Phosphorylation of rOPN did not show a significant effect
on the rate of protein degradation by proteinase K, consis-
tent with no change in the extent of ordered structure. The
susceptibility of rOPN to proteolysis is in clear contrast to
that of the globular protein myoglobin (Fig. S6). AnalysisFIGURE 1 Guinier plots for phosphorylated (A) and unphosphorylated (B)
(q  Rg)% 1.3. (C) Expected Rg values for chemically denatured proteins were
the confidence interval of the Flory equation. The diamonds show experimen
(lighter). The lower continuous gray line shows the expected Rg value for glob
phorylated (gray) rOPN, from which the Rg and Dmax were obtained. (E) Kratkof the 1H NMR chemical shift dispersion of both forms
of rOPN further supports highly flexible unfolded protein
structures (Fig. S7). These results are also reflected in the
hydrodynamic behavior, computational predictions, and
migration behavior on SDS-PAGE gels.
SAXS data of the phosphorylated and unphosphorylated
rOPN are shown in Fig. 1, A and B, respectively. In Fig. 1
C, the radii obtained from the Guinier plots are found
consistent with those expected for IDPs, according to the
Flory equation (67), which postulates a power-law relation-
ship between the radius of gyration Rg and the number N of
residues in a polymer:
Rg ¼ R0Nn; (3)
where R0 is a constant that varies with the persistence length
of the peptide and n is an exponential scaling factor con-
stant. For chemically unfolded proteins (the Rg of bovine
native OPN 1–149 was previously found (68) to match the
predicted radius using these parameters), n and R0 were pre-
viously determined (69) to be 0.65 0.03 and 1.935 0.28,
respectively. Similarly, for globular proteins, accurate pre-
dictions were also made using values of n and R0 equal torOPN. Rg and I0 were recovered from the fits of the straight lines where
determined using Eq. 3, where the region between dashed lines represents
tal Rg obtained for phosphorylated (darker) and unphosphorylated rOPN
ular proteins. (D) P(r) distributions of phosphorylated (black) and unphos-
y plots are shown (same color scheme as D).
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in Fig. 1 C).
The P(r) distributions gave broadly similar results for
both forms of rOPN; the asymmetrical shape of the curves
is characteristic of IDPs (see Fig. 1 D; Table 1). I0 was
used to produce Kratky plots (Fig. 1 E), which display a
plateau at high q from Gaussian chain behavior, character-
istic of highly unfolded or flexible proteins (70). Phosphor-
ylation appears to have minimal effect on the solution
scattering of rOPN, reflecting an overall unchanged confor-
mation at the SAXS resolution. Given the distribution of
phosphorylation sites, a certain degree of averaging of the
structural parameters is plausible. To fully assess this effect,
further studies on phosphorylated peptides are required. The
ensemble-optimization method data for phosphorylated and
unphosphorylated rOPN both display highly extended and
flexible structures. The corresponding Rg and maximum
particle size, Dmax, for the two forms of rOPN, are shown
in Table 1. Fig. 2 shows the respective ensemble fits.Internal protein dynamics observed by neutron
scattering show a change only above the
nanosecond timescale upon phosphorylation
The apparent MSDs obtained for rOPN are shown in Fig. 3:
the linear increase with temperature reflects the onset of
motions faster than the resolution of the spectrometers
used. A steeper increase at ~200 K is typical of a dynamical
transition associatedwith the onset of an anharmonic regime,
often observed for hydrated protein powders. Within noise
level, the MSDs are mostly similar for both forms of rOPN
over nearly the entire temperature range measured. Above
~280 K, a small difference in the apparent MSDs was de-
tected for the IN16B data, and prompted the collection of
full QENS spectra. These were recorded on IRIS at 300 K,
and on IN16B at temperatures of 280 K and lower (Fig. 4).
No differences can be observed between the two forms of
rOPN at 200 K, within experimental error. Minor differences
are only apparent at 280 K and for jZuj < 10 meV, at time-
scales of ~300 ps (beyond what could be observable on the
150-ps scale of the IRIS data). At 300 K (Fig. S10), broader
quasi-elastic wings are noticeable for phosphorylated rOPN.
The following model was used to fit both IRIS and IN16B
spectra:
Sðq;uÞ ¼ R5b½A0ðqÞdðuÞ þ ð1 A0ðqÞÞLðG;uÞ; (4)TABLE 1 Parameters fromAnalysis of the SAXSData on rOPN
Phosphorylated Unphosphorylated
Guinier Rg (A˚) 39.05 0.6 38.65 0.6
I0 13.45 0.1 11.65 0.1
Rg (A˚) from P(r) 39.85 0.2 39.45 0.3
Dmax (A˚) from P(r) 1295 12 1315 13
The confidence level for the uncertainties is 95%.
1590 Biophysical Journal 112, 1586–1596, April 25, 2017where R denotes the instrument energy resolution func-
tion, determined by fitting the spectra of a vanadium foil
(IN16B), or the sample itself at the lowest temperature
(10 K on IRIS), with a sum of Gaussian functions. L(G,u)
is a Lorentzian function with half-width at half-maximum
G accounting for the rOPN internal molecular dynamics.
Center-of-mass diffusion was ignored, given that the sam-
ples used are hydrated powders. A0(q)d(u) models the
elastic contribution in the accessible time window, where
A0(q) is the elastic incoherent structure factor (EISF) that
yields information on the geometry of confinement of the
atoms within the protein. The widths G are plotted as a func-
tion of q2 in Fig. 5. The fits to the IRIS spectra at 300 K
show a trend of larger linewidths for the phosphorylated
sample.
For the IRIS data at 300 K (Fig. S10), as well as for the
IN16B data at 200 and 250 K (Fig. 5), no particular q depen-
dence was observed on the range. A constant GðqÞ ¼ Zt1
can be fitted to the QENS data with an average relaxation
time t. The observation of a q-independent width may indi-
cate that side-chain motions are restricted to localized rota-
tions at low temperature, at the accessible timescale. At
300 K, we obtain relaxation times of 17.1 5 3.8 ps and
29.6 5 1.7 ps for phosphorylated and unphosphorylated
rOPN, respectively. This confirms that the phosphorylation
state influences the internal dynamics of rOPN on the subna-
nosecond timescale (see also Fig. S11) and that, on average,
a shorter time elapses between two side-chain jumps for
phosphorylated rOPN, when compared to the unphosphory-
lated form.
At 280 K, a more marked q dependence is observed,
which can be fitted by a jump-diffusion model (71):
GðqÞ ¼ Dq21þ Dq2t; (5)
whereD is the jump-diffusion coefficient. Such a model was
used in previous studies (72,73) to describe the dynamics of
protein side chains on the nanosecond and picosecond time-
scales. For 200 and 250 K data, the linewidth was fitted as a
global parameter. After the observations on IN16B at 280 K,
a fit was performed for all q simultaneously to keep the error
on the parameters as low as possible, with the scattering
function:
Sðq;uÞ ¼ R5b

A0ðqÞdðuÞ þ/
þ ð1 A0ðqÞÞL

Dq2
1þ Dq2t;u

; (6)
where D and t are global parameters for all scattered wave
vectors. Jump-diffusion coefficients of (4.3 5 2.9)  106
and (2.3 5 0.9)  106 cm2/s were obtained from the fits
for the unphosphorylated and phosphorylated rOPN, respec-
tively. The confidence of the fit is insufficient for quantitative
conclusions on a possiblevariation ofDwith phosphorylation.
FIGURE 2 Ensemble optimization analysis of the HPLC-SAXS profile measured for rOPN peptides. (A) Rg and (B) Dmax distribution for the random
ensemble (solid black line), phosphorylated rOPN (dashed), and unphosphorylated rOPN (dots) is shown. The fits to the corresponding scattering curves
are shown in (C) for phosphorylated rOPN and (D) unphosphorylated rOPN.
Effect of Phosphorylation on OsteopontinIt is, however, noteworthy that both D coefficients do show
observed internal dynamics approximately one order-of-
magnitude faster than the center-of-mass motion of typical
proteins (74), and one order-of-magnitude slower than the
diffusion of water (75).FIGURE 3 Apparent MSDs of the two forms of rOPN, obtained from polynom
(A) on the IRIS and (B) on the IN16B spectrometers. (Both insets) Elastic scatte
show data binned along the temperature-axis to 5 K-intervals. The error bars cor
smaller than the point symbols.The EISF from Eq. 5 is plotted in Fig. 6 for both rOPN
forms. It describes an atom in a Gaussian radial energy land-
scape (76) with effective radius a:
A0ðqÞ ¼ pþ ð1 pÞexp
 ðq  aÞ25; (7)ial non-Gaussian fits to elastic fixed window temperature scans performed:
ring intensities as a function of q2, at 305 K, are given. The point symbols
respond to 1 SD of uncertainty. Note that on the (B) inset, the error bars are
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FIGURE 4 Example QENS spectra measured on IN16B (q ¼ 1.7 A˚1),
and q-wise fit (Eq. 4) at two temperatures, for unphosphorylated (uP) and
phosphorylated (P) rOPN, normalized to their maximum for a better com-
parison. For clarity, the data are rebinned for jZuj> 1 meV. Thewings of the
spectra—jZuj > 15 meV—are the same for both rOPN forms at both tem-
peratures, within the error bars (1 SD of uncertainty).
FIGURE 5 Comparison of the widths for the two rOPN forms. (A) From
fits to IN16B spectra: for 200 and 250 K data, the fits (Eq. 4) are straight
lines. For the 280 K data, a jump diffusion model was used (Eq. 5). The
points at the two highest q values are not shown (signal-to-noise ratio too
high to be included in a reliable data analysis). (B) IRIS spectra and corre-
sponding fits (Eq. 4) at 300 K are given. The lines are guides to the eye. The
error bars correspond to 1 SD of uncertainty.
Lenton et al.where p is the fraction of immobile atoms (immobile will be
used, hereon, not in an absolute sense but in the context of the
instrumental timescales used). We obtain an average value of
3.5 A˚ for the radius a (see Fig. S11), regardless of tempera-
ture and phosphorylation state. The fraction of immobile
atoms can be easily deduced from the high-q value of A0,
and is shown in Fig. 6. For both rOPN forms, p is closer to
1 at the lowest temperature and decreases toward higher
temperatures at the nanosecond resolution. At 280 K, where
the difference between EISFs of the two rOPN forms be-
comes clear, the phosphorylated protein has a larger number
of immobile atoms on the resolution of IN16B. On the much
shorter IRIS resolution timescale (at 300 K), upon phosphor-
ylation, the number of immobile rOPN side chains decreases.
The difference in absolute values between the apparent MSD
data from IRIS and IN16B is then due to the different popu-
lations of motions sampled.
Overall, for phosphorylated rOPN, before applying
any model we observe a larger broadening of the QENS
than for the unphosphorylated rOPN, recorded on both
IRIS at 300 K and IN16B at 280 K (Figs. S4 and S10).
This observation is consistent with the fits of the Lorentzian
G in Eq. 4, which show a larger G for the phosphorylated
samples at the aforementioned temperatures. The increased
flexibility is further supported by the shorter residence times
at 250 and 280 K for the phosphorylated rOPN (Fig. S12).
The results obtained provide further insights into the
motional landscape of rOPN upon phosphorylation:
1) The geometrical confinement (MSDs and p values) and
relaxation of dynamics are unchanged at lower tempera-
tures upon phosphorylation. At 280 K, phosphorylation
appears to induce slightly more extensive confinement1592 Biophysical Journal 112, 1586–1596, April 25, 2017of dynamics. This could be an effect of the larger immo-
bile fraction (with effectively very small confinement).
2) We see a dynamically heterogeneous sample, as reflected
by the q4 term from EINS fits and the separation into
immobile and mobile atoms at 75- and 4-ns timescales.
3) Slower dynamics: for immobile atoms, a large part of the
hydrogen atoms is not moving considerably even on
nanosecond timescales (>67% at 280 K), and it increases
by ~7% (0.73–0.67) at 280 K upon phosphorylation.
The difference likely comes from the serine side chains
directly affected. For mobile atoms, phosphorylation
speeds up the dynamics of mobile atoms, presumably to
compensate for the entropic cost of immobilizing atoms.
The q signature identifies these motions as jump-like
below 280 K, and jump-diffusion-like for 280 K.
FIGURE 6 EISF, A0, for the two forms of rOPN from fits (lines) by Eq. 7.
The fraction of immobile atoms, at the resolution times of each spectrom-
eter, is shown for each plateau: (A) IN16B QENS spectra (~4 ns); see also
Fig. S11 for more information on the fit parameters. (B) IRIS spectra (~15
ps). The effective radius a is 2.635 0.86 A˚ and 2.715 0.36 A˚ for unphos-
phorylated and phosphorylated rOPN, respectively. The data point error
bars correspond to 1 SD of uncertainty.
Effect of Phosphorylation on Osteopontin4) Faster dynamics: at 300 K, phosphorylation unblocks
some immobile atoms (11% ¼ 0.87–0.76). Mobile
atoms appear to have faster dynamics on the pico-
second scale, and the q signature identifies the motions
as mainly jump-like. Possible explanations for this
are only speculative without further data, but at 300
K—closer to physiological conditions—the entropic
cost of immobilizing residues upon phosphorylation
may become too high for a range of rOPN conforma-
tions. Specific, preferred conformations—not suffi-
ciently different from the ensemble for the change to
be reflected on the Rg—may become more populated,
where faster, albeit more confined movements, are
allowed to further compensate for the rigidity of the
PCs. The faster picosecond motions can plausiblyenhance ability to interact with crystal surfaces and
provide a potential advantage in interactions with pre-
nucleation clusters—picosecond-lived species present
in supersaturated solutions of calcium phosphates and
other salts (45).CONCLUSIONS
Phosphorylation effects at various length- and time-scales are
paramount to IDPs, which often use allosteric mechanisms
requiring somewhat long-range intramolecular communica-
tion (77). Proteins can use fast picosecond kinetics to drive
allosteric changes by strategically increasing some and
decreasing other side-chain mobilities (78,79). The relation-
ship between function and the hierarchy of timescales in
protein dynamics is not well understood and there are still
few studies in the literature investigating this in sufficient
level of detail.
In this study, no conformational changes were detected by
small angle scattering on the solution structure of rOPN upon
phosphorylation. This was previously observed for OPN
peptides (48), as well as other phosphorylated proteins
(80). Our studies here show that, overall, phosphorylation
makes side-chain motions faster, but blocks some of the
slower moving residues and releases some of the faster mov-
ing ones. Similar phosphorylation effects were previously
found by NMR relaxation studies (80), where dynamic
changes at the active site were seemingly opposite to those
observed elsewhere in the sequence.
Phosphorylation of rOPN caused a rigidification of some
residues on the accessible timescale. By selectively slowing
nanosecond dynamics of PCs, phosphorylation affords suf-
ficient free energy for sequestration of calcium phosphate
and formation of CPN. Motions of side chains outside the
PCs, on the other hand, can provide an entropic compensa-
tion for the arrest of the phosphorylated residues. The core-
shell structure of CPN is highly dependent on the seques-
tering power of the phosphopeptide (caseins, for example,
are known to form nanoclusters with a calcium phosphate
core structure four times smaller than OPN).
Our results are also consistent with higher (closer to
physiological) temperatures being a trigger to an allosteric
effect of phosphorylation, but further evidence is needed to
unequivocally establish this. We have shown here that
rOPN displays heterogeneous, complex internal molecular
dynamics, and these are known to modulate tertiary and
quaternary contacts. Effects from the extent and mapping
of phosphorylation events, as well as the corresponding
motional landscape, will require further studies.SUPPORTING MATERIAL
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